2010 Annual Meeting | Myelopathies
02:15 PM - 03:00 PM |
Spinal Cord Syndromes and Vascular Myelopathies
Jose Biller, MD, FACP, FAHA, FAAN |
|
03:00 PM - 03:45 PM |
Inflammatory and Infectious Myelopathies
Dean M. Wingerchuk, MD, FAAN |
|
03:45 PM - 04:00 PM |
Break
|
|
04:00 PM - 04:45 PM |
Metabolic and Hereditary Myelopathies
Neeraj Kumar, MD |
|
04:45 PM - 05:30 PM |
Neoplastic and Other Compressive Myelopathies
Julie E. Hammack, MD, FAAN |
|
05:30 PM - 06:00 PM |
Panel Discussion, Interesting Cases, Questions and Answers
|
Neeraj Kumar, MD | Dr. Kumar has nothing to disclose. |
Dean M. Wingerchuk, MD, FAAN | Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TTY Biopharm. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Biopharm. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers. |
Jose Biller, MD, FACP, FAHA, FAAN | Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care. |
Julie E. Hammack, MD, FAAN | Dr. Hammack has nothing to disclose. |